Myriad Genetics Inc vs. Intellia Therapeutics, Inc
Intellia Therapeutics, Inc (NTLA) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| MYGN | NTLA | |
|---|---|---|
| Market Cap | $634.16 million | $1.75 billion |
NTLA leads on 1 of 1 size & scale factors.
Risk & Sentiment
| MYGN | NTLA | |
|---|---|---|
| Short Interest | 13.76% | 2.43% |
NTLA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MYGN overview, MYGN financials, NTLA overview, NTLA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.